The Genetic and Scientific Basis, Molecular Biology, and Mechanistic Rationale for Lowering LDL Through PCSK9 and APOB Inhibition and Other Novel Targets - R. Scott Wright, MD FACC, FESC, FAHA

The Genetic and Scientific Basis, Molecular Biology, and Mechanistic Rationale for Lowering LDL Through PCSK9 and APOB Inhibition and Other Novel Targets - R. Scott Wright, MD FACC, FESC, FAHA

Published

October 29, 2015

Created by

CMEducation Resources symposium